GlassScriptPhysician profile
Melinda A Clark
NPI 1578978557
$1,351.40
in general payments reported to CMS, 2019-2025
14 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $140 · 2022: $62.59 · 2023: $300 · 2024: $410 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $921.35 | 2021-2025 | Puraply, Affinity, Apligraf |
| Smith+Nephew, INC. | $162.16 | 2021-2024 | Renasys Touch, Grafix Pl, Pico |
| Urgo Medical North America, LLC | $36.47 | 2024 | Urgoclean Ag, Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Next Science LLC | $33.56 | 2023 | Blastx, Xperience, Surgx |
| Abbvie INC. | $29.91 | 2022-2023 | |
| Bsn Medical INC | $23.80 | 2025 | |
| Convatec INC. | $23.53 | 2024 | |
| Beone Medicines USA, INC. | $23.44 | 2025 | Tevimbra |
| Janssen Biotech, INC. | $19.64 | 2025 | Talvey |
| Sunovion Pharmaceuticals INC. | $18.70 | 2021 | |
| Hartmann USA, INC. | $15.90 | 2025 | Zetuvit Plus 10x10 P10 |
| Solventum Corporation | $15.83 | 2025 | Activ.A.C. |
| Reprise Biomedical, INC. | $15.13 | 2024 | Miro3d |
| Seagen INC. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melinda Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.